Phase II trial of oxaliplatin in combination with bolus/infusional 5FU/LV (FOLFOX4) in patients with advanced gastrointestinal (GI) cancers with varying degrees of renal impairment

Trial Profile

Phase II trial of oxaliplatin in combination with bolus/infusional 5FU/LV (FOLFOX4) in patients with advanced gastrointestinal (GI) cancers with varying degrees of renal impairment

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2008

At a glance

  • Drugs Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Gastrointestinal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Dec 2008 End date identified from clinicaltrials.gov.
    • 20 Aug 2008 Actual number of patients added (source ClinicalTrials.gov).
    • 20 Aug 2008 Primary endpoint added to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top